This is the authors' abstract. We don't add key points for this paper.
N6-methyladenosine (m 6 A) RNA methylation and circular RNA have been demonstrated to exert a crucial role in diverse malignant tumors, such as esophageal squamous cell carcinoma (ESCC). Nevertheless, the precise regulatory mechanism through which m 6 A-modified circRNA impacts ESCC remains to be elucidated. Herein, we discovered that the methyltransferase WTAP is highly expressed in ESCC and is correlated with a poor prognosis. Knockdown of WTAP significantly diminishes the proliferation, migration, and invasion capabilities of ESCC cells both in vitro and in vivo. The m 6 A-circRNA Epitranscriptomic microarray analysis, MeRIP-qPCR, RT-qPCR, and circularization verification ascertained that circRNA_404908 is the downstream target of WTAP. Knockdown of WTAP reduces the m 6 A level, expression, and stability of circRNA_404908. A series of functional assays indicate that circRNA_404908 facilitates the proliferation, migration, and invasion of ESCC cells, and overexpression of circRNA_404908 can counteract the reduction in cell proliferation, migration, and invasion abilities caused by si-WTAP. Additionally, in vitro experiments demonstrated that circRNA_404908 regulates the expression of ANO1 by sponging miR-3059-5p, thereby promoting the progression of ESCC. Mechanistically, WTAP-mediated m 6 A modification of circRNA_404908 governs the miR-3059-5p/ANO1 axis to facilitate the advancement of ESCC. Collectively, our study reveals that WTAP-mediated m 6 A modification drives ESCC progression via circRNA_404908/miR-3059-5p/ANO1 axis, providing both mechanistic insights into m 6 A-circRNA crosstalk and potential therapeutic targets for ESCC treatment.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: